Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Zink

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Bioorganic & Medicinal Chemistry Letters|November 22, 2007
Design and synthesis of novel and potent amide linked PPARgamma/delta dual agonistsQing Shi, Emily J Canada, Yanping Xu, et al.
Bioorganic & Medicinal Chemistry Letters|September 29, 2006
Synthesis and evaluation of aminomethyl dihydrocinnamates as a new class of PPAR ligandsAlan M Warshawsky, Charles A Alt, Joseph T Brozinick, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2016
Identification of potent and selective retinoic acid receptor gamma (RARγ) antagonists for the treatment of osteoarthritis pain using structure based drug designNorman E Hughes, Thomas J Bleisch, Scott A Jones, et al.
Journal of Medicinal Chemistry|March 15, 2021
Discovery of an Orally Efficacious Positive Allosteric Modulator of the Glucagon-like Peptide-1 ReceptorFrancis S Willard, David B Wainscott, Aaron D Showalter, et al.
Journal of Medicinal Chemistry|November 14, 2003
Design and synthesis of a potent and selective triazolone-based peroxisome proliferator-activated receptor alpha agonistYanping Xu, Daniel Mayhugh, Ashraf Saeed, et al.
Bioorganic & Medicinal Chemistry Letters|March 11, 2015
Design and synthesis of a novel series of [1-(4-hydroxy-benzyl)-1H-indol-5-yloxy]-acetic acid compounds as potent, selective, thyroid hormone receptor β agonistsTimothy P Burkholder, Brian E Cunningham, Joshua R Clayton, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Novel 3-aryl indoles as progesterone receptor antagonists for uterine fibroidsTimothy I Richardson, Christian A Clarke, Kuo-Long Yu, et al.
Bioorganic & Medicinal Chemistry Letters|November 18, 2004
Conversion of human-selective PPARalpha agonists to human/mouse dual agonists: a molecular modeling analysisMinmin Wang, Leonard L Winneroski, Robert J Ardecky, et al.
Journal of Medicinal Chemistry|December 14, 2017
Discovery of LY3104607: A Potent and Selective G Protein-Coupled Receptor 40 (GPR40) Agonist with Optimized Pharmacokinetic Properties to Support Once Daily Oral Treatment in Patients with Type 2 Diabetes MellitusChafiq Hamdouchi, Pranab Maiti, Alan M Warshawsky, et al.
Journal of Medicinal Chemistry|October 18, 2016
The Discovery, Preclinical, and Early Clinical Development of Potent and Selective GPR40 Agonists for the Treatment of Type 2 Diabetes Mellitus (LY2881835, LY2922083, and LY2922470)Chafiq Hamdouchi, Steven D Kahl, Anjana Patel Lewis, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Bioorganic & Medicinal Chemistry Letters|November 22, 2007
Design and synthesis of novel and potent amide linked PPARgamma/delta dual agonistsQing Shi, Emily J Canada, Yanping Xu, et al.
Bioorganic & Medicinal Chemistry Letters|September 29, 2006
Synthesis and evaluation of aminomethyl dihydrocinnamates as a new class of PPAR ligandsAlan M Warshawsky, Charles A Alt, Joseph T Brozinick, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2016
Identification of potent and selective retinoic acid receptor gamma (RARγ) antagonists for the treatment of osteoarthritis pain using structure based drug designNorman E Hughes, Thomas J Bleisch, Scott A Jones, et al.
Journal of Medicinal Chemistry|March 15, 2021
Discovery of an Orally Efficacious Positive Allosteric Modulator of the Glucagon-like Peptide-1 ReceptorFrancis S Willard, David B Wainscott, Aaron D Showalter, et al.
Journal of Medicinal Chemistry|November 14, 2003
Design and synthesis of a potent and selective triazolone-based peroxisome proliferator-activated receptor alpha agonistYanping Xu, Daniel Mayhugh, Ashraf Saeed, et al.
Bioorganic & Medicinal Chemistry Letters|March 11, 2015
Design and synthesis of a novel series of [1-(4-hydroxy-benzyl)-1H-indol-5-yloxy]-acetic acid compounds as potent, selective, thyroid hormone receptor β agonistsTimothy P Burkholder, Brian E Cunningham, Joshua R Clayton, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Novel 3-aryl indoles as progesterone receptor antagonists for uterine fibroidsTimothy I Richardson, Christian A Clarke, Kuo-Long Yu, et al.
Bioorganic & Medicinal Chemistry Letters|November 18, 2004
Conversion of human-selective PPARalpha agonists to human/mouse dual agonists: a molecular modeling analysisMinmin Wang, Leonard L Winneroski, Robert J Ardecky, et al.
Journal of Medicinal Chemistry|December 14, 2017
Discovery of LY3104607: A Potent and Selective G Protein-Coupled Receptor 40 (GPR40) Agonist with Optimized Pharmacokinetic Properties to Support Once Daily Oral Treatment in Patients with Type 2 Diabetes MellitusChafiq Hamdouchi, Pranab Maiti, Alan M Warshawsky, et al.
Journal of Medicinal Chemistry|October 18, 2016
The Discovery, Preclinical, and Early Clinical Development of Potent and Selective GPR40 Agonists for the Treatment of Type 2 Diabetes Mellitus (LY2881835, LY2922083, and LY2922470)Chafiq Hamdouchi, Steven D Kahl, Anjana Patel Lewis, et al.
Pageof 6